Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

ClinicalTrials.gov ID: NCT00130923

Public ClinicalTrials.gov record NCT00130923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)

Study identification

NCT ID: NCT00130923
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Enrollment: 95 participants

Conditions and interventions

Conditions

Interventions

Risperidone Long Acting Drug
oral risperidone Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2005
Primary completion: May 31, 2009
Completion: Jun 30, 2010
Last update posted: May 8, 2019

2005 – 2010

United States locations

U.S. sites: 8
U.S. states: 5
U.S. cities: 8

Facility	City	State	ZIP	Site status
JMH Mental Health Center, University of Miami	Miami	Florida	33136	—
School of Pharmacy, Univ. of Missouri Kansas City	Kansas City	Missouri	64108	—
Washington University School of Medicine	St Louis	Missouri	63110	—
West Central Behavioral Health	Lebanon	New Hampshire	03766	—
Mental Health Center of Greater Manchester	Manchester	New Hampshire	03101	—
Center for Psychiatric Advancement	Nashua	New Hampshire	03060	—
University of South Carolina	Columbia	South Carolina	29203	—
White River Junction Veterans Admininistration Medical Center	White River Junction	Vermont	05009	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00130923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 8, 2019 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00130923 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →